Xin Lang Cai Jing·2025-12-24 02:53Core Viewpoint - Baiyunshan Pharmaceutical Group Co., Ltd. has shown a mixed performance in financing activities and stockholder dynamics, with significant revenue growth and stable profit margins in recent financial reports [2][3]. Financing Activities - On December 23, Baiyunshan's stock price increased by 0.12%, with a trading volume of 236 million yuan. The financing buy-in amount for the day was 20.09 million yuan, while the financing repayment was 33.61 million yuan, resulting in a net financing outflow of 13.52 million yuan [1]. - As of December 23, the total financing and securities lending balance for Baiyunshan was 920 million yuan, with the financing balance of 918 million yuan accounting for 2.53% of the circulating market value, indicating a high level compared to the past year [1]. - In terms of securities lending, Baiyunshan repaid 200 shares and sold 44,600 shares on December 23, with a selling amount of 1.15 million yuan. The remaining securities lending volume was 97,900 shares, with a balance of 2.53 million yuan, also at a high level compared to the past year [1]. Company Overview - Baiyunshan, established on September 1, 1997, and listed on February 6, 2001, is based in Guangzhou, Guangdong Province. The company specializes in the research, development, manufacturing, and sales of traditional Chinese and Western medicines, chemical raw materials, and health products [2]. - The revenue composition of Baiyunshan includes 69.32% from large commercial operations, 16.79% from health products, and 12.53% from traditional Chinese medicine, with specific contributions from various segments [2]. - As of September 30, 2025, Baiyunshan reported a revenue of 61.61 billion yuan, reflecting a year-on-year growth of 4.31%, and a net profit attributable to shareholders of 3.31 billion yuan, with a growth of 4.78% [2]. Dividend Distribution - Since its A-share listing, Baiyunshan has distributed a total of 10.91 billion yuan in dividends, with 4.36 billion yuan distributed over the past three years [3]. Shareholder Dynamics - As of September 30, 2025, Baiyunshan had 101,700 shareholders, an increase of 18.85% from the previous period. The average number of circulating shares per shareholder remained unchanged at 0 shares [2]. - Among the top ten circulating shareholders, China Securities Finance Corporation holds 47.28 million shares, unchanged from the previous period, while Hong Kong Central Clearing Limited reduced its holdings by 20.44 million shares [3].